-
March 23, 2011
April 27 – 28, 2011 in Philadelphia, PA ~ Prepare for REMS Assessments and Increase Risk Awareness among Interval and External...
-
June 10, 2010
January 9-12, 2011 in Washington, DC ~
Clinical trial safety and postmarketing pharmacovigilance is more critical than ever in the development...
-
June 9, 2010
January 24-25, 2011 in Arlington, VA ~ Practical Strategies for Determining Risk Thresholds, Implementing and Assessing REMS Programs.
Any risk management...
-
June 1, 2010
January 26 – 27, 2011 in Washington , DC ~
Risk-Benefit Assessment for Diabetes and Oncology Therapies
Current Regulatory Perspective on Increases...
-
May 11, 2010
February 24 – 25, 2011 in London , United Kingdom ~
CBI’s 6th Forum on Late Phase Research, Drug Safety and...
-
April 17, 2010
April 27-28, 2011 in Philadelphia, PA ~
The purpose of the REMS is to ensure the benefit of the drug outweighs...
-
April 5, 2010
March 21 – 22, 2011 in Philadelphia, PA ~
The purpose of the REMS is to ensure the benefit of the...
